Provenge: Q2043 No Longer Includes Admin -- Claim Your $71

Don't miss the effective date for this change.

Medicare offered some positive news for practices providing Provenge. The administration is now separately billable.

History: In Transmittal 2254, dated July 8, 2011, CMS announced that Q2043 (Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion) included all related services. The transmittal specifically listed administration as not separately billable.

But a new transmittal changes all that by stating that you may report the administration separately.

What's new: CMS rescinded Transmittal 2254 and replaced it with Transmittal 2239, dated Nov. 2, 2011, announced Roberta Buell, MBA, [...]

- Published on 2011-12-09